Keith haddock houston

Schulman as well as others who will serve in a transitional role. Keith Haddock will oversee and coordinate activities in the Houston location. Long-term decisions have not yet been made on the Houston office. What can you tell us about A. Headquartered in Akron, Ohio, A. Schulman is a leading international supplier of high-performance plastic compounds and resins.

These materials are used in a variety of consumer, industrial, automotive and packaging applications. The Company employs about 2, people and has 17 manufacturing facilities in North America, Europe and Asia.

They are very excited to have ICO join their company. We see many synergies and expanded opportunities for both sets of customers. Why is A. Schulman the best company to acquire ICO? The businesses of A. Schulman and ICO are extremely complementary across markets, product lines and geographies.

Schulman, we have met a number of wonderful, enthusiastic and energized people and we are confident that the chemistry between our two teams will be excellent. All inquiries from the media should be referred to Jennifer Beeman in corporate communications in Akron. We see this as a very positive move for both companies. Schulman, we have determined that, while there were other options, this step was in the best interests of our business to continue to grow.

Investors Why did you decide to finance the acquisition this way? Our strengthened financial position has given us the ability and flexibility to invest in strategic acquisitions. We believe the combination of cash and stock provides the highest impact for the business, generates maximum return on invested capital, is the best use of cash on hand, and provides us additional financial flexibility going forward. What are the fees associated with this transaction?

How much cost savings are you anticipating, once the two organizations are integrated? This does not include any additional manufacturing and sales synergies that may be generated after the two companies are fully integrated. We are beginning the process of identifying those synergies now. To complete the integration, is A. Our two businesses are extremely complementary across product lines and geography.

This transaction is about growth and opportunity in two markets that we have targeted — masterbatch and rotomolding. We will continue to examine the business and make strategic decisions based on our markets and demand.

What about management of the combined entity — how will it change? The key business leaders of ICO will remain with the organization including the leaders of each of the ICO business units. John Knapp will no longer serve as CEO. Barmore and Eugene R. Allspach, will be joining the A. Schulman Board of Directors. How different are the technology platforms? This is usually one of the areas that slows down integration. How are you preparing for that? Schulman and ICO financial systems to ensure information flow during the short term.

Our business leaders have plans to develop a longer-term strategy to move toward a common system platform. In the case where systems may not be similar, we will provide training for those impacted associates.

What percent of customers do the two companies share? However, we expect to have little overlap, given that our two businesses are extremely complementary across product lines and geography. Will my supply of product be affected? No immediate changes will occur to any processes relating to the supply of product as a result of the merger.

The levels of quality, availability and lead-time that you have come to expect will not change. The same holds true for the production location of your products.

Total number of pages in all volumes: []. Total number of sealed volumes: 1. Method of Filing Paper Copies: mail. Number of pages: [34]. Sufficient: YES. Number of Copies: [1].

Number of days granted: 5. United States v. Search this Docket. Bovis Lend Lease Inc, 4th Cir. Docket Entries Filed. Ascending Descending. Walker S. Poston, Ph. He has published over peer-reviewed scientific journal articles, book chapters, and books on a variety of topics related to cardiovascular disease epidemiology and treatment, primarily in the area of obesity and tobacco cessation.

Sara Anne Jahnke, Ph. Jahnke is a Principal Investigator for the National Development and Research Institutes where she does research on cardiovascular, injury, and nutrition epidemiology. Christopher K. Haddock, Ph.